Nursing Care Plan and Medical Management for 1-Year-Old Post-Ileostomy Closure with Improving Infection
Continue the current piperacillin-tazobactam and gentamicin regimen, as this combination is guideline-recommended for complicated intra-abdominal infections in pediatric patients and the infant is showing clinical improvement. 1
Medical Management: Antibiotic Therapy
Current Regimen Appropriateness
- Piperacillin-tazobactam plus gentamicin is an acceptable broad-spectrum regimen for pediatric patients with complicated intra-abdominal infections, as recommended by the Infectious Diseases Society of America 1
- The combination provides coverage against enteric gram-negative organisms (E. coli) and anaerobes (Bacteroides species), which are the primary pathogens in post-surgical intra-abdominal infections 2
- Piperacillin-tazobactam alone provides adequate anaerobic coverage, making metronidazole unnecessary in this regimen 2
Dosing Verification for 1-Year-Old
- Piperacillin component: 240-300 mg/kg/day IV divided every 6-8 hours (higher end of dosing range if undrained abscesses present) 1, 2
- Gentamicin: 5-7.5 mg/kg/dose IV every 24 hours (once-daily dosing preferred) 1
- Monitor gentamicin trough levels targeting <2 mcg/mL to minimize ototoxicity and nephrotoxicity 3
- Monitor serum creatinine and renal function throughout therapy 1, 3
Duration of Therapy
- Limit antibiotics to 3-5 days postoperatively if adequate source control was achieved during ileostomy closure 1, 2
- Prolonging antibiotics beyond 3-5 days offers no benefit and increases antimicrobial resistance risk when source control is adequate 1, 2
- If source control was incomplete or concerns exist about residual infection, extend therapy but reassess daily for discontinuation 1
Monitoring for Treatment Response
- Assess for resolution of fever, normalization of white blood cell count, and improved feeding tolerance 4
- Evaluate surgical site for signs of wound infection, dehiscence, or anastomotic complications 5
- Monitor for adverse drug reactions including rash (common in piperacillin therapy), diarrhea, and electrolyte abnormalities 6
Nursing Care Plan
Infection Monitoring
- Monitor vital signs every 4 hours, with particular attention to temperature trends and heart rate normalization 4
- Assess surgical incision site every shift for erythema, drainage, dehiscence, or signs of deep infection 5
- Monitor white blood cell count and C-reactive protein trends if initially elevated 4
- Document stool output characteristics (frequency, consistency, presence of blood) as indicators of bowel function recovery 5
Fluid and Electrolyte Management
- Monitor strict intake and output given the sodium load from piperacillin-tazobactam (54 mg sodium per gram of piperacillin) 6
- At typical dosing, the infant receives significant sodium (approximately 2.35 mEq per gram of piperacillin), requiring monitoring for fluid overload 6
- Assess for signs of fluid retention: weight gain, edema, increased work of breathing 6
- Monitor serum electrolytes, particularly sodium and potassium, every 2-3 days during antibiotic therapy 6
Renal Function Monitoring
- Monitor serum creatinine at baseline and every 2-3 days during gentamicin therapy 1, 3
- Calculate creatinine clearance to ensure appropriate dosing adjustments if renal function declines 6
- Assess urine output hourly; notify physician if <1 mL/kg/hour, as both piperacillin-tazobactam and gentamicin are renally excreted 6
Nutritional Support
- Advance enteral feeds as tolerated, monitoring for signs of feeding intolerance (abdominal distension, emesis, increased gastric residuals) 5
- Post-ileostomy closure patients may have temporary malabsorption; monitor weight and nutritional status 5
- Collaborate with dietitian for appropriate caloric goals in this post-surgical infant 5
Surgical Site Care
- Maintain clean, dry surgical dressing with changes per institutional protocol or when soiled 5
- Assess for wound dehiscence, a known complication after ileostomy reversal in infants 5
- Monitor for signs of anastomotic complications including abdominal distension, bilious emesis, or bloody stools 5
Developmental and Family-Centered Care
- Provide age-appropriate pain assessment using validated pediatric pain scales (FLACC for non-verbal infants) 4
- Encourage parental involvement in care activities (feeding, holding, comfort measures) 4
- Educate parents on signs of infection recurrence requiring immediate medical attention: fever, lethargy, feeding refusal, abdominal distension 4
Critical Pitfalls to Avoid
Antibiotic-Related
- Do not add metronidazole to the current regimen, as piperacillin-tazobactam already provides adequate anaerobic coverage 2
- Do not extend antibiotics beyond 3-5 days without clear indication, as this increases resistance without improving outcomes 1, 2
- Do not use aminoglycosides without monitoring serum levels and renal function, as nephrotoxicity and ototoxicity risks are significant 1, 3
Clinical Management
- Do not overlook signs of anastomotic complications (obstruction, leak, stricture), which occur in approximately 10-15% of post-ileostomy closure patients 5
- Do not ignore persistent fever beyond 48-72 hours of appropriate antibiotics, as this may indicate inadequate source control or resistant organisms 4
- Do not use antimotility agents if diarrhea develops, as these may worsen outcomes in infectious enterocolitis 7
Monitoring Failures
- Do not fail to adjust gentamicin dosing based on renal function, as accumulation leads to toxicity 1, 3
- Do not overlook fluid overload from sodium content in piperacillin-tazobactam, particularly in infants with cardiac or renal compromise 6
Transition Planning
- Plan for antibiotic discontinuation at 3-5 days if clinical improvement continues (afebrile >24 hours, tolerating feeds, normal inflammatory markers) 1, 2
- Schedule follow-up within 1-2 weeks post-discharge to assess surgical site healing and ensure no late complications 5
- Educate parents on signs requiring urgent evaluation: fever, vomiting, abdominal distension, decreased urine output, lethargy 4